TP53 and cardiomyopathy: Cyclophosphamide-induced activation of p53 protein is considered as one of the possible mechanisms for cardiomyopathy, and it is reported that probucol supplementation restored cyclophosphamide-induced upregulation of p53 and reversed apoptosis in cardiomyocytes [49].